Medicared For All Logo

Konstantinos Leventakos in Rochester, Minnesota

Home Minnesota Rochester

Konstantinos Leventakos has Medical Oncology as his primary medical specialty. Their primary office is: 200 1st St Sw in Rochester, Minnesota.

They're a part of the: Mayo Clinic medical group which has around 4,240 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2005 (around 19 years of experience). They are listed as doing telehealth appointments.


Konstantinos Leventakos Office Phone and Directions

Konstantinos Leventakos
Mayo Clinic
200 1st St Sw
Rochester, Minnesota 55905
-


Patient Ratings
Please rate your experience with Konstantinos Leventakos below to help others make a more informed decision. Thanks!
Current Rating: Loading...


Enter a starting address:


Healthcare Info for Konstantinos Leventakos

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Konstantinos Leventakos is listed as: Medical Oncology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 4284858861
NPI #: 1326338070
NPI Created On: 04/14/2011
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207RH0003X
License Number:
57811
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medica Health Plans of Wisconsin
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Greek.


Services and Procedures include:

  1. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  2. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  3. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  4. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  5. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  6. Infusion of chemotherapy into a vein up to 1 hour
  7. Infusion of chemotherapy into a vein
  8. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  9. New patient office or other outpatient visit, typically 60 minutes
  10. Established patient office or other outpatient visit, typically 5 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 40 minutes
  13. Subsequent hospital inpatient care, typically 35 minutes per day
  14. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
  15. Injection, leucovorin calcium, per 50 mg
  16. Injection, dexamethasone sodium phosphate, 1 mg
  17. Injection, diphenhydramine hcl, up to 50 mg
  18. Injection, ondansetron hydrochloride, per 1 mg
  19. Unclassified drugs
  20. Injection, bortezomib (velcade), 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1,838

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

Third party is a Charity:: No

Record ID:: 820046459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ALUNBRIG

Open Associated Drug #1: 63020-090-07


Payments Total: $2,220

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 834346111

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TAGRISSO

Open Associated Drug #1: 0310-1349-30


Payments Total: $1,590

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 845606441

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HEMATOLOGY/ONCOLOGY

Name of Drug #1: ZEPZELCA

Open Associated Drug #1: 68727-712-01


Medical Oncology Professionals in Rochester

200 1st St Sw
Rochester, MN
Mayo Clinic

200 1st St Sw
Rochester, MN
Mayo Clinic

1216 2nd Swst
Rochester, MN
Mayo Clinic

200 1st St Sw
Rochester, MN
Mayo Clinic

200 1st St Sw
Rochester, MN
Mayo Clinic

200 1st St Sw
Rochester, MN
Mayo Clinic

Providers in Mayo Clinic

1.Christopher Aakre

1216 2nd Swst
Rochester Mn 55902-1906
Mayo Clinic
Internal Medicine

2.Christopher Aakre

200 1st St Sw
Rochester Mn 55905-0001
Mayo Clinic
Internal Medicine

3.Muhannad Abbasi

200 1st St Sw
Rochester Mn 55905-0001
Mayo Clinic
Cardiovascular Disease (cardiology)

4.Arnoley Abcejo

200 1st St Sw
Rochester Mn 55905-0001
Mayo Clinic
Anesthesiology

5.Nadine Abdallah

200 1st St Sw
Rochester Mn 55905-0001
Mayo Clinic
Hematology

6.Sarah Abdallah

200 1st St Sw
Rochester Mn 55905-0001
Mayo Clinic
Physical Therapy

View all 4,240 members of Mayo Clinic medical group